ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005

ASCO Awards Contract For D.C. Office

January 5, 1990

Rising Obesity May Result In Higher Cancer Incidence

August 27, 2010

DCT Board Approves Concepts For New RFA, New And Recompeting Contracts

June 18, 1982

First Lady Helps Dedicate New MDA Facilities

October 15, 1976

Overwhelming 89 To 7 Vote By Senate Overturns President Reagan’s Veto Of NIH Reauthorization

November 29, 1985